Rgenix Inc., a start-up from the Rockefeller University lab of co-founder and scientific advisor Sohail Tavazoie, landed a $33 million series B financing led by Novo A/S and Sofinnova Partners. Existing investors, including the Partnership Fund for New York City, Alexandria Venture Investments and Conegliano Ventures LP, also participated.